| English | German |
| Alpha-1-Antitrypsin Deficiency | Alpha-1-Antitrypsinmangel |
| Alpha-1-Antitrypsin Deficiency | Laurell-Eriksson-Syndrom |
| Alpha-1-Antitrypsin Deficiency | α1-Antitrypsinmangel |
| Alpha-1-Antitrypsin Deficiency | Proteaseinhibitormangel |
| Alpha-1-Antitrypsin Deficiency | AAT-Defizit |
| 1-benzylpiperazine | 1-Benzylpiperazin |
| breast cancer gene 1 | brustkrebsförderndes Gen 1 |
| D1 receptor | D1-Rezeptor |
| 1, 2-dibromo-3-chloropropane | 1,2-Dibromo-3-chlorpropan |
| foot-and-mouth disease strain Asia 1 | Maul- und Klauenseuche des ASIA 1-Stammes |
| fructose 1, 6-diphosphate | Fructose-1.6-Diphosphat |
| glycoprotein 1 | Virusglycoprotein 1 |
| 2009 H1N1 flu | Neue Grippe |
| 2009 H1N1 flu | Influenza AH1N1v |
| H1N1 flu | A/H1N1-Grippe |
| human immunodeficiency virus type 1 | Humanes Immunschwäche-Virus |
| human T cell lymphotropic virus 1 | Humanes T-Zell-Leukämie-Virus vom Typ I |
| inositol 1, 4, 5-triphosphate | Inosit-1,4,5-Triphosphat |
| insulin-like growth factor-1 | insulin-ähnlicher Wachstumsfaktor I |
| 1< | E850 |
| 1< | Carbadox |
| Management Committee COST B1 - Criteria for the Choice and Definition of Healthy Volunteers and/or Patients for Phase I and II Studies in Drug Development | Verwaltungsausschuß COST B 1 Kriterien für die Auswahl und Definition von gesunden Probanden und/oder Patienten für Phase I- und II-Studien während der Entwicklung von Arzneimitteln |
| 5-methyl-1H-pyrimidine-2, 4-dione | 5-Methyluracil |
| 5-methyl-1H-pyrimidine-2, 4-dione | Thymin |
| 5-methyl-1H-pyrimidine-2, 4-dione | 2,4-Dihydroxy-5-methylpyrimidin |
| 1-(4-amino-2-propylpyrimidin-5-yl) methyl-2-methyl-pyridinium chloride hydrochloride | E750 |
| 1-(4-amino-2-propylpyrimidin-5-yl) methyl-2-methyl-pyridinium chloride hydrochloride | Amprolium |
| 2-N-2'-(hydroxyethyl) carbamoyl-3-methylquinoxaline-N1, N4-dioxide | Olaquindox |
| 2-N-2'-(hydroxyethyl) carbamoyl-3-methylquinoxaline-N1, N4-dioxide | E851 |
| mono-esters of propane-1, 2-diol propylene glycol and edible fatty acids, alone or in mixtures with diesters | Propylenglycolester von Speisefettsäuren |
| mono-esters of propane-1, 2-diol propylene glycol and edible fatty acids, alone or in mixtures with diesters | Monoester von Propylenglykol 1,2-Propandiol und von Speisefettsäuren, allein oder mit Diestern gemischt |
| neurofibromatosis type 1 | Neurofibromatose (neurofibromatosis) |
| neurofibromatosis type 1 | Von-Recklinghausen-Krankheit (neurofibromatosis) |
| New Delhi metallo-beta-lactamase-1 | New Delhi metallo-beta-lactamase |
| N-methyl-1-4-methoxyphenyl-2-aminopropane | Paramethoxymethamphetamin |
| N-methyl-1-4-methoxyphenyl-2-aminopropane | N-Methyl-1-4-methoxyphenyl-2-aminopropan |
| novel H1N1 flu | Influenza AH1N1v |
| novel H1N1 flu | Neue Grippe |
| 1-phenyl-2-propanone | 1-Phenyl-2-Propanon |
| propane-1, 2-diol esters of fatty acids | Monoester von Propylenglykol 1,2-Propandiol und von Speisefettsäuren, allein oder mit Diestern gemischt |
| role 1 facility | Einrichtung der Versorgungsebene 1 |
